Corcept Therapeutics to Announce Third Quarter 2016 Financial Results and Corporate Update and Host Conference Call
(firmenpresse) - MENLO PARK, CA -- (Marketwired) -- 10/26/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on November 1, 2016. The Company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).
To participate, dial 1-800-446-1671 from the United States or 1-847-413-3362 internationally approximately 10 minutes before the start of the call. The passcode is 43632675.
A replay will be available through November 15, 2016 at 1-888-843-7419 from the United States and
1-630-652-3042 internationally. The passcode is 43632675.
Corcept is a pharmaceutical company engaged in the discovery, development and commercialization of drugs that treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of cortisol. Korlym® (mifepristone) 300 mg tablets, a first-generation cortisol modulator, is the company's first FDA-approved medication. The company also has a portfolio of proprietary compounds that modulate the effects of cortisol but not progesterone. Corcept owns extensive intellectual property covering the use of cortisol modulators, including mifepristone, in the treatment of a wide variety of serious disorders. It also holds composition of matter patents covering its selective cortisol modulators.
CONTACT:
Charles Robb
Chief Financial Officer
Corcept Therapeutics
650-688-8783
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.10.2016 - 12:30 Uhr
Sprache: Deutsch
News-ID 502901
Anzahl Zeichen: 0
contact information:
Town:
MENLO PARK, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 162 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Corcept Therapeutics to Announce Third Quarter 2016 Financial Results and Corporate Update and Host Conference Call"
steht unter der journalistisch-redaktionellen Verantwortung von
Corcept Therapeutics (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
